NEW DRUG IN THE EVOLUTION OF LONG-ACTING INSULINS
Медицинский совет, 2018 Insulin glargine, synthesized using recombinant DNA technology in a concentration of 100 U/ml, was the first once-daily longacting insulin analogue introduced into clinical practice in 2000.
I. V. Kononenko, O. M. Smirnova
doaj +1 more source
Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease [PDF]
, 2012 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Christopher J Cates +3 more
core +1 more source
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes [PDF]
, 2004 Objectives: To assess the clinical and cost-effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) in the delivery of intensive insulin therapy for the treatment of diabetes mellitus.
Green, C. +9 more
core +1 more source
Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial [PDF]
, 2015 Introduction Evening-time exercise is a frequent cause of severe hypoglycemia in type 1 diabetes, fear of which deters participation in regular exercise.
Gonzalez, JT +22 more
core +1 more source
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease (Review) [PDF]
, 2011 BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropiumare commonly used, either on their own or in combination, for managing persistent symptoms of chronic obstructive pulmonary disease ...
Christopher J Cates +3 more
core +1 more source
Symposium: New horizons in the treatment of type 1 diabetes mellitus. New insulins. Smart insulin
Revista de la Sociedad Argentina de Diabetes, 2021 In 1921, Dr. Banting's impressive intuition led to discovery and subsequent crystallization of insulin in Toronto University. Its administration to the patient Leonard Thompson marked a historic milestone in humanity and immediately determined a ...
Guillermo Dieuzeide
doaj +1 more source
Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease [PDF]
, 2011 Background Long-acting beta2-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However,
David J Evans +12 more
core +1 more source
Long-acting beta2-agonists for chronic obstructive pulmonary disease. [PDF]
, 2013 BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up.
Walters, JA +5 more
core +1 more source
Diabetology & Metabolic Syndrome, 2022 Background To assess the impact of long-acting insulin analogues, compared to intermediate acting neutral protamine Hagedron (NPH), on maternal, perinatal and neonatal outcomes.
Jijiao Wang +3 more
doaj +1 more source
Spanish Journal of Medicine, 2022 Aim: The aim of this study was to analyze the patterns of insulin consumption between 2014 and 2018 in Cádiz. Methods: This study was a cross-sectional retrospective study. All people that used any insulin were included in the study.
José Escribano-Serrano +7 more
doaj +1 more source